InvestorsHub Logo

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
DNORWOOD Free
03/04/24 6:32 PM
profile icon
The Canes Free
02/29/24 7:06 PM
profile icon
DNORWOOD Free
02/29/24 4:01 PM
profile icon
DNORWOOD Free
02/29/24 7:08 AM
profile icon
DNORWOOD Free
02/28/24 7:20 PM
profile icon
The Canes Free
02/28/24 4:44 PM
profile icon
DNORWOOD Free
02/28/24 12:28 PM
profile icon
DNORWOOD Free
02/27/24 7:10 PM
profile icon
The Canes Free
02/27/24 5:01 PM
Bullish
Bullish
profile icon
DNORWOOD Free
02/27/24 2:26 PM
profile icon
DNORWOOD Free
02/26/24 9:23 PM
profile icon
DNORWOOD Free
02/26/24 8:45 AM
profile icon
DNORWOOD Free
02/23/24 8:33 PM
profile icon
AliasUser1 Free
02/23/24 1:23 PM
profile icon
DNORWOOD Free
02/23/24 6:09 AM
profile icon
DNORWOOD Free
02/22/24 9:28 AM
profile icon
DNORWOOD Free
02/21/24 3:24 PM
profile icon
DNORWOOD Free
02/21/24 10:18 AM
profile icon
Monksdream PremiumMember
02/21/24 1:39 AM
profile icon
Liam859 Free
02/20/24 4:24 AM
profile icon
trendzone Free
02/16/24 2:25 PM
profile icon
Liam859 Free
01/03/24 5:34 AM
profile icon
Penny Trades Free
11/24/23 5:06 PM
profile icon
Monksdream PremiumMember
11/06/23 12:58 PM
profile icon
Monksdream PremiumMember
10/07/23 4:55 PM
profile icon
Monksdream PremiumMember
10/05/23 7:54 AM
profile icon
NY1972 Free
10/01/23 11:38 PM
profile icon
jondoeuk Free
10/01/23 5:26 PM
Bearish
Bearish
profile icon
Monksdream PremiumMember
09/26/23 3:04 PM
profile icon
Monksdream PremiumMember
09/24/23 12:09 PM
profile icon
The Canes Free
09/07/23 4:47 AM
profile icon
Monksdream PremiumMember
08/26/23 1:28 PM
profile icon
Monksdream PremiumMember
08/26/23 1:27 PM
profile icon
Monksdream PremiumMember
08/16/23 1:25 PM
profile icon
Monksdream PremiumMember
08/14/23 2:17 PM
profile icon
seve333 Free
08/09/23 6:03 PM
profile icon
AJ Freely Free
07/17/23 8:16 AM
profile icon
The Canes Free
03/29/23 11:43 AM
profile icon
jondoeuk Free
02/16/23 8:37 PM
profile icon
TechandBio Free
01/11/23 5:41 PM
Bullish
Bullish
profile icon
MWM Free
01/09/21 4:08 PM
profile icon
MWM Free
12/31/20 3:44 PM
profile icon
The Canes Free
12/31/20 3:25 PM
profile icon
Fress Free
12/29/20 8:42 AM
profile icon
hitekmastr Free
12/28/20 1:54 PM

Sangamo Biosciences Inc (SGMO) RSS Feed

Followers
72
Posters
132
Posts (Today)
0
Posts (Total)
461
Created
09/09/04
Type
Free
Moderators



http://www.sangamo.com/index.php

http://finance.yahoo.com/q/ks?s=SGMO+Key+Statistics

Sangamo Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on translating ground-breaking science into genomic therapies that transform patients' lives using platform technologies in genome editing, gene therapy, gene regulation, and cell therapy. The company?s proprietary zinc finger DNA-binding protein (ZFP) technology enables specific genome editing and gene regulation. The ZFPs could be engineered to make ZFP nucleases (ZFNs), proteins that could be used to specifically modify DNA sequences by adding or knocking out specific genes; and ZFP transcription factors (ZFP TFs), proteins that can be used to turn genes on or off. Its therapeutic products include SB-728-T, a ZFN-mediated autologous T-cell product for human immunodeficiency virus and acquired immunodeficiency syndrome (HIV/AIDS), which is in Phase II and Phase I clinical trials; and SB-728-HSPC that is in Phase I/II clinical trials for HIV/AIDS. The company also engages in Phase I/II studies of in vivo genome editing applications of ZFP Therapeutics for hemophilia B, Hemophilia A, and Mucopolysaccharidosis I (MPS) and MPS II, which are lysosomal storage disorder (LSD); proprietary preclinical programs in other LSDs; and research stage programs in certain central nervous system disorders and cancer immunotherapies. It has collaborative partnerships with Biogen Inc. to develop therapeutic genome editing products in hemoglobinopathies; and with Shire International GmbH to develop the preclinical development program in Huntington?s disease, as well as license agreement with Sigma-Aldrich Corporation to develop ZFP-based laboratory research reagents and Dow AgroSciences, LLC to modify the genomes or alter protein expression of plant cells, plants, or plant cell cultures. The company was formerly known as Sangamo BioSciences, Inc. and changed its name to Sangamo Therapeutics, Inc. in January 2017. Sangamo Therapeutics, Inc. was founded in 1995 and is headquartered in Richmond, California.

Volume:
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
New Post